Description
MIF-1 research peptide
MIF-1 (Pro-Leu-Gly-NH2) is an endogenous tripeptide derived from oxytocin. It modulates dopamine and opioid receptor signalling and is studied in neuropharmacology.
Product details
| Compound | MIF-1 (melanocyte-inhibiting factor) |
|---|---|
| Class | Endogenous tripeptide (Pro-Leu-Gly-NH2) |
| Strength | 5mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What research has examined
- Dopamine receptor modulation: allosteric effects at D2 receptors.
- Opioid research: anti-opioid activity in animal models.
- Neuropeptide history: one of the first hypothalamic peptides studied for CNS effects.
Research interest does not establish a proven effect in humans.
Regulatory status
This compound is not an approved medicine. It is supplied only as a research chemical for laboratory use.
Storage and handling
Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.
Related research products
Alpha Klotho LR · DSIP Spray · VIP Spray · All peptides
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.